The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
By Jean-Pierre Lindenmayer, David Brown, Sherry Liu,
Psychopharmacology Bulletin VOL 41 No. 3 Articles
Authors can request a digital copy of their article gratis by emailing editorial@medworksmedia.com. Please put “Author Request” in the subject line. No third parties please. Advisory Board members in good standing can request anyitem in the database. Please put “Advisory Board Request” in the subject line.
-
EVIDENCE-BASED MEDICINE
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
By Patricia Berney, Demian Halperin, Rodrigo Tango, Isabelle Daeniker-Dayer, Pierre Schulz
-
ORIGINAL RESEARCHCocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia
By Arija Maat, Annemarie Fouwels, Lieuwe de Haan
-
GENERAL PSYCHIATRYPlacebo Response in Depression: A Perspective for Clinical Practice
By Arif Khan, Shirin Khan
-
EVIDENCE-BASED MEDICINE
Psychometric Evaluation of a Patient-Rated Troubling Symptom Scale for Generalized Anxiety Disorder Clinical Trials
By Gahan J. Pandina, Dennis A. Revicki, Leah Kleinman, Ibrahim Turkoz, Jasmanda Wu, Ramy Mahmoud, Georges M. Gharabawi
-
EVIDENCE-BASED MEDICINE
Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example
By Ree Dawson, Alan I. Green, Robert E. Drake, Thomas H. McGlashan, Bella Schanzer, Philip W. Lavori